Nedaplatin in nasopharyngeal cancer: the rebirth of platinum salts?

Pierre Blanchard; Yungan Tao

doi:10.1016/S1470-2045(18)30113-X

Nedaplatin in nasopharyngeal cancer: the rebirth of platinum salts?

Pierre Blanchard, Yungan Tao

Research output: Contribution to journal › Comment/debate

6 Citations (Scopus)

Original language	English
Pages (from-to)	429-431
Number of pages	3
Journal	The Lancet Oncology
Volume	19
Issue number	4
DOIs	https://doi.org/10.1016/S1470-2045(18)30113-X
Publication status	Published - 1 Apr 2018

Access to Document

10.1016/S1470-2045(18)30113-X

Cite this

@article{70e6d61e572545ef86dff4ce173780ad,

title = "Nedaplatin in nasopharyngeal cancer: the rebirth of platinum salts?",

author = "Pierre Blanchard and Yungan Tao",

note = "Funding Information: PB reports grants and non-financial support from Astellas Pharma, and non-financial support from Merck Serono. YT declares no competing interests.",

year = "2018",

month = apr,

day = "1",

doi = "10.1016/S1470-2045(18)30113-X",

language = "English",

volume = "19",

pages = "429--431",

journal = "The Lancet Oncology",

issn = "1470-2045",

number = "4",

}

TY - JOUR

T1 - Nedaplatin in nasopharyngeal cancer

T2 - the rebirth of platinum salts?

AU - Blanchard, Pierre

AU - Tao, Yungan

N1 - Funding Information: PB reports grants and non-financial support from Astellas Pharma, and non-financial support from Merck Serono. YT declares no competing interests.

PY - 2018/4/1

Y1 - 2018/4/1

UR - http://www.scopus.com/inward/record.url?scp=85042588268&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(18)30113-X

DO - 10.1016/S1470-2045(18)30113-X

M3 - Comment/debate

C2 - 29501364

AN - SCOPUS:85042588268

SN - 1470-2045

VL - 19

SP - 429

EP - 431

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 4

ER -

Nedaplatin in nasopharyngeal cancer: the rebirth of platinum salts?

Access to Document

Other files and links

Cite this